series-b
Stage
1
Investors
About
Chase Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of improved treatments for neurodegenerative diseases, including Parkinson's disease.
Explore Chase Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.